New‐onset guttate psoriasis secondary to COVID‐19
Abstract SARS‐CoV‐2, the virus that causes coronavirus disease 2019 (COVID‐19), is associated with flares of psoriasis in patients with well‐documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25‐yea...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-07-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.4542 |
| Summary: | Abstract SARS‐CoV‐2, the virus that causes coronavirus disease 2019 (COVID‐19), is associated with flares of psoriasis in patients with well‐documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25‐year‐old male patient who presented a first‐onset guttate psoriasis following a COVID‐19 infection. We have not found previous descriptions of de novo guttate psoriasis post‐COVID‐19. |
|---|---|
| ISSN: | 2050-0904 |